Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Hepatology Communications
|
November 10, 2018
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis
Mark R Deneau, Cara Mack, Reham Abdou, et al.
Hepatology (Baltimore, Md.)
|
May 19, 2021
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
Mercedes Martinez, Emily R Perito, Pamela Valentino, et al.
Alimentary Pharmacology & Therapeutics
|
March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium
Amanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Hepatology (Baltimore, Md.)
|
April 9, 2017
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
Mark R Deneau, Wael El-Matary, Pamela L Valentino, et al.
Hepatology (Baltimore, Md.)
|
May 29, 2020
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children
Mark R Deneau, Cara Mack, Emily R Perito, et al.
Hepatology (Baltimore, Md.)
|
September 7, 2022
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
Daniel H Leung, Sridevi Devaraj, Nathan P Goodrich, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Hepatology Communications
|
November 10, 2018
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis
Mark R Deneau, Cara Mack, Reham Abdou, et al.
Hepatology (Baltimore, Md.)
|
May 19, 2021
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
Mercedes Martinez, Emily R Perito, Pamela Valentino, et al.
Alimentary Pharmacology & Therapeutics
|
March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium
Amanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Hepatology (Baltimore, Md.)
|
April 9, 2017
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration
Mark R Deneau, Wael El-Matary, Pamela L Valentino, et al.
Hepatology (Baltimore, Md.)
|
May 29, 2020
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children
Mark R Deneau, Cara Mack, Emily R Perito, et al.
Hepatology (Baltimore, Md.)
|
September 7, 2022
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
Daniel H Leung, Sridevi Devaraj, Nathan P Goodrich, et al.
Page
of 9